Abstract:TLR8-mediated NF-kappaB and IRF7 activation are abolished in human IRAK-deficient 293 cells and IRAK4-deficient fibroblast cells. Both wild-type and kinase-inactive mutants of IRAK and IRAK4, respectively, restored TLR8-mediated NF-kappaB and IRF7 activation in the IRAK- and IRAK4-deficient cells, indicating that the kinase activity of IRAK and IRAK4 is probably redundant for TLR8-mediated signaling. We recently found that TLR8 mediates a unique NF-kappaB activation pathway in human 293 cells and mouse embryonic fibroblasts, accompanied only by IkappaBalpha phosphorylation and not IkappaBalpha degradation, whereas interleukin (IL)-1 stimulation causes both IkappaBalpha phosphorylation and degradation. The intermediate signaling events mediated by IL-1 (including IRAK modifications and degradation and TAK1 activation) were not detected in cells stimulated by TLR8 ligands. TLR8 ligands trigger similar levels of IkappaBalpha phosphorylation and NF-kappaB and JNK activation in TAK1(-/-) mouse embryo fibroblasts (MEFs) as compared with wild-type MEFs, whereas lack of TAK1 results in reduced IL-1-mediated NF-kappaB activation and abolished IL-1-induced JNK activation. The above results indicate that although TLR8-mediated NF-kappaB and JNK activation are IRAK-dependent, they do not require IRAK modification and are TAK1-independent. On the other hand, TLR8-mediated IkappaBalpha phosphorylation, NF-kappaB, and JNK activation are completely abolished in MEKK3(-/-) MEFs, whereas IL-1-mediated signaling was only moderately reduced in these deficient MEFs as compared with wild-type cells. The differences between IL-1R- and TLR8-mediated NF-kappaB activation are also reflected at the level of IkappaB kinase (IKK) complex. TLR8 ligands induced IKKgamma phosphorylation, whereas IKKalpha/beta phosphorylation and IKKgamma ubiquitination that can be induced by IL-1 were not detected in cells treated with TLR8 ligands. We postulate that TLR8-mediated MEKK3-dependent IKKgamma phosphorylation might play an important role in the activation of IKK complex, leading to IkappaBalpha phosphorylation.

TAK1 Knockdown Enhances Lipopolysaccharide-Induced Secretion of Proinflammatory Cytokines in Myeloid Cells Via Unleashing MEKK3 Activity.

TAK1 Negatively Regulates NF-κB and P38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils.

TAOK1 positively regulates TLR4-induced inflammatory responses by promoting ERK1/2 activation in macrophages.

Inhibitor of Tec Kinase, LFM-A13, Decreases Pro-Inflammatory Mediators Production in LPS-stimulated RAW264.7 Macrophages Via NF-κB Pathway

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX)

Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.

Camkii Promotes Tlr-Triggered Proinflammatory Cytokine And Type I Interferon Production By Directly Binding And Activating Tak1 And Irf3 In Macrophages

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is Required for Interleukin (Il)-1-mediated Optimal NFκB and AP-1 Activation As Well As IL-6 Gene Expression

KINETICS OF MITOGEN-ACTIVATED PROTEIN KINASE FAMILY IN LIPOPOLYSACCHARIDE-STIMULATED MOUSE KUPFFER CELLS AND THEIR ROLE IN CYTOKINE PRODUCTION

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses

Functional Involvement of TANK‐Binding Kinase 1 in the MyD88‐Dependent NF‐ κ B Pathway Through Syk

Lysine 63-Linked Polyubiquitination of TAK1 at Lysine 158 is Required for Tumor Necrosis Factor Α- and Interleukin-1β-induced IKK/NF-κB and JNK/AP-1 Activation

TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent

TRIM26 Positively Regulates the Inflammatory Immune Response Through K11-linked Ubiquitination of TAB1

TAK1-binding protein 2 (TAB2) and TAB3 are redundantly required for TLR-induced cytokine production in macrophages

Myeloid Cell TBK1 Restricts Inflammatory Responses

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Keap1 Silencing Boosts Lipopolysaccharide-Induced Transcription of Interleukin 6 Via Activation of Nuclear Factor Κb in Macrophages.